
Maia Fertility
Maia Fertility Ltd. made its first steps at the Weizmann Institute of Science.
Backed by more than 25 years of experience in enzyme technology, protein engineering, biophysics, biochemistry and bio-molecular techniques, Maia Fertility is dedicated to advancing reproductive health through a breakthrough approach to embryo implantation. By harnessing the power of natural enzymes, we significantly enhance the rate of embryo implantation and consequently increase the chances of conception.
Maia Fertility’s vision is to improve the implantation rate of mammalian embryos, redefining the future of reproductive medicine..
Maia Fertility brings together scientific and business world leaders who share the passion to improve reproduction of both animal and human. Our team has vast experience in biological sciences and in managing business platforms.

Dr. Eldar Zehorai
Co-Founder and VP R&D
A former postdoctoral fellow at Prof. Irit Sagi’s lab, Department of Biological Regulation, Weizmann Institute of Science. Ph.D. in the field of Signal Transduction, Weizmann Institute of Science.

Prof. Irit Sagi
Co-Founder and Senior Scientific Consultant
Professor and former VP of Tech Transfer in YEDA, Weizmann Institute of Science. Recipient of Inventor of the Year Award (2006), Juludan Prize for Outstanding Research Projects (2013), Landau Prize in Biochemistry (2017) and the EMBO-FEBS Women in Science Lecture Award (2019)

Dr. Nir Arbel
CEO
A serial entraupenuer in life science. Has been serving in senior roles in startups and public companies over the past 15 years

Mr. Asher Grinbaum
Chair of Maia Fertility ltd. board
Served as Acting Chief Executive Officer of Israel Chemicals Limited until 2018. Before, was the Chief Operating Officer and Executive Vice President of Israel Chemicals.

Adv. Oded Savorai
Board member .
A highly accomplished litigator, strategist and a Founding Partner of a premier Israeli law firm. With a distinguished career spanning decades, he is widely recognized for his expertise in navigating complex environments and representing clients in the country’s most sensitive, high profile cases.
